POP-1, a Tcf/Lef-1-like target of the convergent Wnt and MAP kinase (MAPK) signaling pathways, functions throughout Caenorhabditis elegans development to generate unequal daughters during asymmetric cell divisions. A particularly prominent such asymmetric division occurs when the EMS blastomere divides to produce MS, a mesoderm precursor, and E, the sole endoderm progenitor. POP-1 allows mesoderm development in the MS lineage by repressing the endoderm-promoting end-1 and end-3 genes. This repression is relieved in the E lineage by Wnt/MAPK signaling, which results in phosphorylation and export of POP-1 from the E nucleus. Here, we report that, in addition to repressing E development in MS, POP-1 also functions positively in endoderm development, in conjunction with the well-characterized endoderm-promoting SKN-1YMED regulatory cascade. While removal of POP-1 alone results in derepression of endoderm development in the MS lineage, mutations in several genes that result in impenetrant loss of endoderm are strongly enhanced by loss of pop-1 function. A Lef-1-like binding site is essential for activation of an end-1 promoter fusion, suggesting that POP-1 may act directly on end-1. Thus, POP-1 may generate developmental asymmetry during many cell divisions in C. elegans by reiteratively switching from repressive and activating states. Furthermore, we report that the Caudal-like homeodomain protein PAL-1, whose role in early embryogenesis was thought to be exclusive specification of mesectodermal development in the lineage of the C blastomere, can act with POP-1 to activate endoderm specification in the absence of the SKN-1YMED transcriptional input, accounting for the impenetrance of mutants lacking SKN-1 or MED-1,2 activity. We conclude that the combined action of several separate transcriptional regulatory inputs, including SKN-1, the MEDs, PAL-1, and the Wnt/MAPK-activated form of POP-1, are responsible for activating end gene transcription and endoderm development. D
Introduction
The Wnt signaling pathway functions in a large number of cellular activities in metazoans, including cell type specification, cell polarization, spindle orientation, control of cell division, and morphogenesis (Cadigan and Nusse, 1997; Miller and Moon, 1996; Moon et al., 2002; Roose and Clevers, 1999) . In the nematode Caenorhabditis elegans, the Wnt pathway acts reiteratively throughout development to direct the developmentally asymmetric division of cells resulting in dissimilar daughters (Eisenmann et al., 1998; Herman, 2001; Herman and Wu, 2004; Lin et al., 1998; Maloof et al., 1999) . The generation of unequal daughter cells by Wnt signaling during C. elegans development is first seen in the four-cell embryo ( Fig. 1) (Rocheleau et al., 1997; Thorpe et al., 1997) . At this stage, the posterior-most blastomere, P 2 , sends a polarizing inductive signal to its neighbor, the EMS mesendoderm progenitor. Upon division of EMS, the side that had received the P 2 signal gives rise to the endoderm progenitor, or E cell; the opposite side, which received no signal, generates the mesoderm-generating MS cell (Goldstein, 1992 (Goldstein, , 1993 (Goldstein, , 1995 Schierenberg, 1987) . The inductive signals emanating from P 2 activate a Wnt pathway, a MAP kinase (MAPK) signaling cascade, and an Src-type tyrosine kinase signal, which collaborate to polarize EMS (Bei et al., 2002; Ishitani et al., 1999; Meneghini et al., 1999; Rocheleau et al., 1997; Thorpe et al., 1997) .
Wnt/MAPK/Src signaling apparently functions in endoderm induction by inactivating POP-1, a TCF/LEF-related repressor of E-specific gene activity. In the MS cell, unsignaled POP-1 represses endoderm-specific gene activity, allowing mesoderm development to occur (Lin et al., 1995; Rocheleau et al., 1997; Thorpe et al., 1997) . Several lines of evidence led to the view that the Wnt/MAPK/Src signaling functions to abrogate the endoderm-repressing activity of POP-1 rather than acting positively to direct endoderm development. First, in the absence of POP-1 activity, both E and MS produce endoderm independent of Wnt/MAPK/Src signaling (Lin et al., 1995 (Lin et al., , 1998 . Second, a complex of the h-catenin-like molecule, WRM-1, and an MAPK component, LIT-1, can phosphorylate POP-1 in vitro (Rocheleau et al., 1999) , and phosphorylation has been shown to disrupt the DNA-binding properties of other TCF/Lef factors (Ishitani et al., 2003) . Third, nuclear POP-1 levels are reduced in the E cell in response to Wnt/MAPK signaling as a result of redistribution of the protein to the cytoplasm mediated by the 14-3-3 protein PAR-5 Lin et al., 1998; Lo et al., 2004; Meneghini et al., 1999) . Similarly, expression of WRM-1 and LIT-1 results in relocalization of POP-1 from the nucleus to the cytoplasm in cultured mammalian cells (Rocheleau et al., 1997) .
Induction of endoderm by a double negative pathway originally suggested that the Wnt pathway functions differently in C. elegans than in other organisms (Lin et al., 1995 (Lin et al., , 1998 Rocheleau et al., 1997; Thorpe et al., 1997) . More recently, it has been shown that, in the absence of signaling, TCF/LEF proteins can function as repressors through their association with Groucho-like co-repressors (Brantjes et al., 2001; Cavallo et al., 1998) . Indeed, the repression of endoderm fate in the MS cell appears to involve a similar complex formed by POP-1, the Groucho-like protein UNC-37, and the histone deacetylase HDA-1 (Calvo et al., 2001) , showing that the repressive role of non-Wnt signaled POP-1 has been evolutionarily conserved. However, while nuclear POP-1 levels decrease in response to Wnt/MAPK signaling, significant levels of POP-1 are nonetheless detected in the E nucleus (Lin et al., 1995 (Lin et al., , 1998 , suggesting that it may also function in signaled cells. Indeed, postembryonically, POP-1 associates with the h-catenin BAR-1 to activate the Wnt target gene mab-5 (Korswagen et al., 2000) , and in gonadogenesis, WRM-1 and LIT-1 are required to activate POP-1 function rather than to abrogate its function (Siegfried and Kimble, 2002) . It therefore remains a possibility that Wnt-signaled POP-1 may also perform an as yet undetected function in endoderm development.
Endoderm is specified by two redundant, zygotically expressed GATA-type transcription factors that are sufficient and together essential for endoderm development Zhu et al., 1997) . The end genes are expressed exclusively in the early E lineage in response to activation by the zygotically expressed MED-1,2 proteins, redundant, non-canonical GATA transcription factors. Expression of the med genes in the E and MS lineage is initiated by the maternally provided SKN-1 transcription factor, and the SKN-1YMED pathway specifies development of both E and MS (Bowerman et al., 1992; Maduro et al., 2001; . While the SKN-1YMED pathway is absolutely essential for MS development,¨30% of embryos lacking SKN-1 and¨50% of embryos lacking MED-1,2 generate gut, indicating that an SKN-1, MED-independent mechanism also specifies endoderm.
In embryos that do not make endoderm as a result of defects in the SKN-1YMEDYEND pathway, the E cell adopts the fate of its cousin, the C blastomere, which gives rise to mesectoderm (muscle, epidermis, and neurons). Conversion to a C-like blastomere, as well as the normal C fate, requires maternal contribution of the Caudal-like homeodomain protein PAL-1 (Hunter and Kenyon, 1996) . While maternal PAL-1, like SKN-1, is expressed in both the (A) In the canonical Wnt pathway, Wnt signaling results in activation of a bipartite transcription factor consisting of h-catenin and a TCF/Lef factor, which activates target genes (reviewed in Cadigan and Nusse, 1997) . In the absence of the Wnt signal, TCF/Lefs can function as repressors (not shown on the figure) (Kim et al., 2000; Merrill et al., 2001) . A similar pathway is proposed to exist for postembryonic C. elegans signaling events (Herman, 2001; Herman and Wu, 2004; Korswagen et al., 2000) . (B) The Wnt pathway as previously described for C. elegans E specification. At the 4-cell stage, P 2 polarizes the ventral blastomere EMS (depicted by shading of the EMS cytoplasm) such that its posterior daughter becomes E. The terminal TCF/Lef-1-like regulator, POP-1, represses E specification in MS by preventing activation of end-1,3 by the SKN-1/MED-1,2 pathway (Calvo et al., 2001; Maduro et al., 2001) . A newly hatched L1 animal is diagrammed showing the 20 E nuclei (dots) that constitute the intestine.
C and E lineages, no function has been ascribed to endoderm-expressed PAL-1.
We report here that, although the SKN-1YMED cascade is required for high levels of end-1 expression, end-1 is expressed at low levels in the absence of SKN-1 or MED-1,2, consistent with the impenetrance of the endoderm specification defect in skn-1 and med-1,2 mutants. We found that Wnt-modified POP-1 is responsible in part for this SKN-1, MED-independent activation of end-1 and endoderm development and that a Lef-1-like site is essential for activation of end-1, consistent with a positive role for POP-1 in endoderm development. These findings suggest that POP-1 is converted from a repressor to an activator of endoderm gene expression. We also made the unexpected finding that PAL-1 activates endoderm in the E lineage when the SKN-1YMED pathway is inactive. Thus, the positive action of POP-1 and PAL-1 on end gene expression accounts for the impenetrance of mutants lacking SKN-1, and the SKN-1YMED, Wnt-activated POP-1, and PAL-1 pathways can function independently to activate endoderm development in C. elegans.
Materials and methods

C. elegans strains and genetics
The following strains were used: N2 [wild type], EU1 [skn-1(zu67) IV/nT1[unc-?(n754) let-?(m435)] (IV;V)], JJ1057 [pop-1(zu189) dpy-5(e61) I/hT1 (I;V); him-
[pop-1(zu189) dpy-5(e61)/hT1 (I;V); end-3(zu247) V/hT1 him-5(e1490) V], and MS162 [med-1(ok804) X; dpy-17(e164) sDf127 unc-32(e189) III; irDp1 (III;f)]. The ok804 mutation deletes the entire med-1 locus, and the deficiency sDf127 deletes med-2 (data not shown). The free duplication irDp1 balances dpy-17 and sDf127 and includes an integrated array containing unc-32(+), an unc-119::YFP reporter used to identify animals carrying irDp1, and additional copies of med-1(+). The deletion ok1448 deletes the DNA-binding domain of END-3 (data not shown). A detailed description of MS162 and RB1331 will be presented elsewhere.
Constructs and transgenic animals
The 5V-deleted promoter constructs were amplified by PCR from pJZ21, an end-1 minigene reporter containing 1.7 kbp of noncoding 5V DNA fused to an end-1 cDNA fragment encoding amino acids 1 -191 of the 221-aa END-1 coding region inserted into plasmid pPD96.04 (NLS::GFP::lacZ::unc-54 _ 3VUTR; a gift from A. Fire). Animals containing 5V-deleted promoter::reporter fusions were obtained by injecting gel-purified PCR products derived from pJZ21 as template. The SKN-1 and GATA sites in construct E265 were substituted by use of an imperfect 3V oligonucleotide, and deletion of the À165 Lef site was performed using a PCR-based cloning strategy with the enzyme EarI; both constructs were cloned into pPD96.04, the critical regions were sequenced, and then the promoter::reporter segment was amplified by PCR for injection. Oligonucleotide sequences and cloning details are available on request. For injections, the marker pRF4 (rol-6D) was used, and DNA mixtures were injected at a concentration of 10-100 ng/Al. Chromosomal integrants for the constructs E1720, Er880, and Er880DLef were obtained from an extrachromosomal line following irradiation at 400 J/m 2 using a UV crosslinker (Stratagene) and identification of integrants in the F 2 generation.
RNA interference (RNAi)
dsRNA was synthesized using the MEGAscript kit (Ambion) from T7 promoter-tagged fragments of cDNA clones as described . For experiments involving skn-1(RNAi) and pop-1(RNAi), soaking of parent animals in dsRNA (Timmons and Fire, 1998 ) was found to be as effective as direct gonadal injection . For soaking experiments, 10 to 50 gravid adult hermaphrodites were immersed in 4 Al dsRNA (¨4 Ag/Al) in RNasefree water for 8 -12 h then recovered on seeded plates for 12-15 h prior to embryo collection for phenotype analysis or X-gal staining. For injection, dsRNA at a concentration of¨4 Ag/Al was injected into both gonad arms of 10-20 hermaphrodites, and animals were allowed to recover for 12 -15 h. For RNAi soaking or injection experiments targeted to multiple genes, equimolar mixtures of the dsRNAs were used. For dsRNA delivery into strain MS162, animals were fed E. coli HT115 expressing dsRNA corresponding to a fragment of the pop-1 or pal-1 cDNAs (Timmons et al., 2001) . All experiments were performed at 20-C.
X-gal staining
Ten to 100 adult gravid worms were placed in the lid of an microfuge tube, and all liquid was removed before placing on dry ice for a minimum of 10 min. Worms were then lyophilized for 1 h, then cold ethanol was added, followed by the slow addition of PBST. Worms were washed 2Â, and then 100 Al of X-gal staining solution was added (Fire, 1992) . Stain was developed at 37-C until visible. Strength of reporter expression was judged based on both intensity of staining as well as time taken to see signal.
Antibody staining
Staining was performed on methanol -acetone fixed embryos as described (Zhu et al., 1997) . h-galactosidase (lacZ) was detected using a monoclonal h-gal Ab (Promega #Z3781), and intestine was detected with the monoclonal Ab MH33 (a gift from R. Waterston). Secondary antibodies were obtained from Sigma.
Results
Endoderm-specific expression of end-1 is regulated by SKN-1, the MEDs, POP-1, and the Wnt pathway
We sought to characterize the regulatory inputs that direct the expression of end-1 to the E lineage by examining expression of an end-1 gene reporter in embryos defective for genes required for normal endoderm development. A 1.7 kb end-1 sequence upstream of the apparent transcriptional start site is sufficient to direct robust expression of a lacZ reporter in the early E lineage, similar to that of the endogenous RNA revealed by in situ hybridization (Zhu et al., 1997) ; however, while transcripts are first detectable in the E cell, reporter expression is not apparent until after E has divided, likely owing to the short length of the E cell cycle and a temporal requirement for transgene product accumulation. This sequence, coupled to the end-1 coding region and 3VUTR, is sufficient to restore endoderm development in transgenic embryos homozygous for a deficiency that eliminates end-1 and its redundant partner end-3 and which otherwise never produces endoderm Zhu et al., 1997) .
We first assessed the requirement for the SKN-1YMED pathway on end-1 expression. We previously found that depletion of med-1,2 function by RNAi results in reduced expression of an end-1 reporter . To test the effect of removing the contribution of med-1, med-2, and skn-1 together, we examined expression of an end-1 reporter in embryos depleted for skn-1; such embryos show no detectable expression of med-1,2, which are apparent direct targets of SKN-1 action . 49% (n = 350) of skn-1(RNAi) embryos fail to express the end-1 reporter entirely, while the remainder express it at substantially reduced levels, consistent with the impenetrant lack of gut in skn-1 mutants (see below). These observations also suggest that end-1 can activate endoderm development even when expressed at diminished levels.
A comparison of the requirement for SKN-1 and the MEDs suggests that SKN-1 provides both MED-dependent and -independent inputs into end gene transcription. While a large fraction of both skn-1 and med-1,2 mutant embryos lack endoderm,¨30% of skn-1(zu67) mutants and¨50% of med-1,2(RNAi) embryos contain a differentiated gut (Bowerman et al., 1992; Maduro et al., 2001) . This difference in penetrance might be attributable to the lower efficacy of RNAi compared to a chromosomal mutation or may reflect a greater requirement for SKN-1 than the MEDs for endoderm specification. To address these alternatives, we examined embryos lacking the chromosomal copies of both med-1 and -2 by constructing a strain carrying the med-1(ok804) X deletion identified by the C. elegans Knockout Consortium and the deficiency sDf127 III, which removes many genes including med-2 (data not shown). Consistent with our observations of med-1,2(RNAi) embryos, we found that 45% (n = 260) of med-1(ok804); sDf127 embryos, which appear to lack all MED activity, make endoderm (Table 1 ). These findings suggest that some SKN-1 may be independent of the MEDs; for example, it may act directly on the end genes, consistent with the presence of SKN-1 sites in these genes (see below; Zhu et al., 1997) .
We next examined the effect of eliminating the endoderm-inducing Wnt pathway on end-1 expression. We found that the end-1 reporter is often expressed in embryos lacking maternal MOM-2, the Wnt-like molecule apparently produced by P 2 that induces endoderm in EMS (Rocheleau et al., 1997; Thorpe et al., 1997) . As with the skn-1 mutants, the fraction of embryos expressing end-1 is greater than the fraction that produces endoderm: in the mom-2(or42) mutant,¨28% of the embryos contain a gut (Thorpe et al., 1997) , yet¨50% express the end-1 reporter, albeit at a reduced level (Fig. 2E ). Embryos lacking both MOM-2 and SKN-1 virtually never contain a gut (Thorpe et al., 1997) , Table 1 Intestinal differentiation in mutant embryos
99% (79) a Scored by presence of birefringent gut granules in terminal embryos. b Soaking of parent hermaphrodites in dsRNA was used. The proportion of gutless embryos was found to be comparable to results obtained by direct injection.
c Direct injection of dsRNA into parent hermaphrodites was used. d sDf127 deletes med-2 and is linked to recessive mutations in dpy-17 and unc-32.
e Growth of hermaphrodite parents on E. coli HT115 bacteria expressing dsRNA was used.
suggesting that the Wnt pathway and SKN-1 function in parallel to activate endoderm development. We found thaẗ 19% of skn-1(zu67); mom-2 (or42) embryos express the end-1 reporter (Fig. 2F) . Thus, the Wnt pathway and SKN-1 collaborate to activate end-1 expression; however, the residual expression in the double mutant suggests that there is yet another factor that activates end-1 (see below).
Maternal POP-1, which represses endoderm differentiation in the MS lineage, is the target of the endoderminducing Wnt signal. We found that elimination of maternal POP-1 by either a chromosomal pop-1 mutation or by RNAi results in expression of the end-1 reporter in descendants of both the E and MS blastomeres (Fig. 2G) , supporting the view that the major role of POP-1 in endoderm specification is as a repressor of end-1 (and end-3) in MS (Calvo et al., 2001; .
Potential conserved regulatory elements in end-1 include consensus binding sites for SKN-1, POP-1, and GATA factors
The foregoing studies establish that end-1 transcription is regulated by the SKN-1YMED pathway and POP-1. Immunoreactive SKN-1 and POP-1 are both found in the nucleus of the E blastomere (Bowerman et al., 1993; Lin et al., 1995) , as are GFP-or myc-tagged versions of MED-1 . MED-1 binds to two sites in the end-1 promoter both in vitro and in vivo (Broitman- Maduro et al., 2005; . To assess the potential of POP-1, SKN-1, and END-1/3 to interact directly with the end-1 promoter, we examined the regulatory regions of end-1, end-3, and homologs of end-1 and end-3 in the related species C. briggsae ( Fig. 3) (Maduro et al., in press; Zhu et al., 1997) . C. briggsae is estimated to have diverged from C. elegans¨50-120 Myr ago, and comparisons of noncoding regions between these species can be used to establish sites important for regulation (Coghlan and Wolfe, 2002; Kennedy et al., 1993) . A number of sequences corresponding to consensus recognition sites for known transcription factors are apparent in the regulatory regions of all four end genes. Consensus binding sites for SKN-1 (RTCAT) (Blackwell et al., 1994) , GATA factors (HGATAR) (Lowry and Atchley, 2000) , and the newly identified MED-1 binding site (RAGTATAC) (Broitman-Maduro et al., 2005) are present at several positions, often in close proximity (Fig. 3) . Within C. elegans end-1, for example, a cluster of five SKN-1 sites extends from À570 to À1000 bp, suggesting that this region might act as a SKN-1-responsive module. In addition, two sequences that match the consensus binding site for the mammalian homolog of POP-1, Tcf/Lef-1 (CTTTGWW) (Lin et al., 1995; Travis et al., 1991) are present in end-1; we will refer to these as Lef-1 sites. Ce-end-1, Ce-end-3, and Cb-end-1 all contain at least one Lef-1 site within the proximal-most 200 bp. As POP-1 can bind to Lef-1 sites (Korswagen et al., 2000) , these are excellent candidates for sites of direct POP-1 regulation. Based on the sequences of their upstream regulatory regions, we conclude that the end genes in C. elegans and C. briggsae may be directly controlled by the regulatory inputs described above, including POP-1.
Requirement for a Lef-1 site in end-1 activation As there are numerous putative transcription factor binding sites in end-1, we sought to simplify the analysis of the promoter by identifying a minimal region capable of directing E lineage-specific expression of end-1. A series of 5V deletions was created in the end-1::lacZ reporter and transgenic embryos assayed for h-galactosidase expression. Sequential removal of distal promoter segments revealed that each contributes incremental activating functions; however, none of these is essential for proper spatial and temporal regulation of end-1 in the E lineage (Fig. 4 and data not shown). Removal of a cluster of SKN-1 sites between À570 and À1000 bp results in greatly reduced reporter expression levels, consistent with the aforementioned genetic data suggesting that SKN-1 provides MED-independent endoderm specifying activity. Furthermore, comparison of deletion constructs differing in retention of a single GATA site at À414 bp (E1000 vs. Er880 and E487 vs. E402) reveals that this site contributes positively to end-1 activation. While MED-1 does not bind to a canonical GATA site (Broitman- Maduro et al., 2005) , the contribution of this site to end-1 activation implicates autoregulation by END-1 or activation by END-3. Recombinant END-1 protein can bind a canonical GATA site, suggesting that END-1 recognizes a GATA site in C. elegans (Shoichet et al., 2000) .
These analyses demonstrated that the proximal-most 310 bp of the end-1 promoter (construct E310) is sufficient for expression of the reporter specifically in the E lineage. Further removal of an additional 95 bp results in sporadic ectopic expression outside of the E and MS lineages later in embryogenesis. However, this minimal 215 bp construct contains all elements sufficient for activation of some end-1 expression in the E lineage, as well as repression in the MS lineage, as it does not show increased expression in MS above the trace amount detected with the full-length promoter (not shown).
The consensus binding sites in the minimal 215 bp segment include Lef-1, SKN-1, MED-1, and GATA sites (Fig. 4) . We predicted that POP-1 might repress end-1 by acting through this Lef-1 site; in such an event, removal of the site would be expected to cause a pop-1(À)-like phenotype, resulting in expression in both the E and MS lineages. To our surprise, either upstream deletion (E158) or precise removal (E310DLef) of the Lef-1 site abolished expression of the end-1 reporter. This result indicates that the Lef-1 site may also be required for activation, in addition Fig. 3 . Putative regulatory sites in the upstream sequences of the end genes of C. elegans and C. briggsae. Sites are denoted by symbols above each promoter (thick line) if they reside on the top strand and below if they reside on the bottom strand. A legend for the symbols used, and the corresponding consensus sequence, is shown at the bottom of the figure. Based on 5V RACE analysis, the 5Vends of the end-1 and end-3 transcripts are within <5 bp of their respective translation start sites (Maduro et al., in press; Zhu et al., 1997) . For consistency, coordinates are given relative to translation start sites (arrows). In C. briggsae, there are two end-3 homologs expressed as divergent transcripts from an intervening 3024 bp promoter. All five end genes show E lineage-specific expression in C. elegans (Maduro et al., in press; Zhu et al., 1997). to repression, of end-1. If indeed this site is recognized by POP-1, it would contrast with the prevailing view that POP-1 function as a repressor of endoderm is merely downregulated in E and hence lacks a function when modified by Wnt/MAPK signaling.
POP-1 acts synergistically with SKN-1 to activate end-1 expression and endoderm development
The finding that an Lef-1 site is essential for end-1 expression led us to consider the possibility that POP-1, which binds to Lef-1 target sequences (Korswagen et al., 2000) , may function as an activator of end-1 in the E cell. This activating function could account for the ability of embryos to make endoderm in the absence of SKN-1 or the MEDs (Bowerman et al., 1992; Maduro et al., 2001) . Such an activating role for POP-1 would likely have eluded detection in pop-1 mutants owing to robust activation of end-1 by SKN-1 and MED-1,2. In a mutant lacking maternal pop-1 function, MS-specific repression is eliminated and SKN-1 and MED-1,2 can activate end-1 in both cells (Fig.  2G) , thereby masking the requirement for a positive role for Fig. 4 . Identification of a minimal end-1 promoter and requirement for candidate cis-acting sites. Fragments of the 1.7-kbp end-1 promoter that were cloned into the vector pPD96.04 are shown alongside the construct name (i.e. FE1720_ for the full-length promoter) and a representation of end-1 reporter levels, based on the X-gal staining of fixed embryos. À, +, ++, +++, and ++++ denote successive levels of signal (++++, strongest signal; +, weak signal; À, no signal detectable). Putative transcription factor binding sites are shown as in Fig. 3. POP-1. An activating role for POP-1 in the E lineage would therefore be evident only when SKN-1 is absent.
We found that simultaneous depletion of SKN-1 and POP-1 by RNAi reveals a requirement for POP-1 in activation of end-1. While 88% of POP-1-depleted and 51% of SKN-1-depleted embryos express the end-1 reporter, only 21% of embryos depleted for both SKN-1 and POP-1 expressed the reporter (Fig. 5) . The decrease in the fraction of embryos expressing the reporter was highly significant ( P < 0.00001 for skn-1 vs. skn-1; pop-1 mutants). This synergistic effect of removing both POP-1 and SKN-1 was reflected not only in the fraction of embryos expressing the reporter, but also in the expression levels observed: skn-1(RNAi); pop-1(RNAi) embryos express the reporter at substantially lower levels than embryos depleted for the function of either gene alone (Fig. 6) . Together, these findings demonstrate that POP-1 contributes positively to end-1 expression in the E lineage.
We next determined whether the decrease in end-1 reporter expression in pop-1(À); skn-1(À) double mutants compared to skn-1(À) mutants alone is reflected as a decrease in the proportion of embryos producing endoderm. We scored for production of differentiated gut by gut granule birefringence, expression of an intestine-specific marker (elt-2::GFP) (Fukushige et al., 1998) , and presence of an intestine-specific antigen detected with the antibody (Bossinger et al., 2004) in terminally differentiated embryos. In all three cases, pop-1(RNAi); skn-1(RNAi) mutants showed a highly significant ( P < 0.0003), 2-to 3-fold decrease in the number of embryos producing gut compared to skn-1(RNAi) single mutants, while controls with unc-22(RNAi); skn-1(RNAi) did not result in such a decrease. The proportion of skn-1(RNAi); pop-1(RNAi) embryos that produce differentiated gut was less than the fraction expressing the end-1 reporter, similar to the results obtained with skn-1 and mom-2 mutant embryos.
It was previously reported that a skn-1(zu67); pop-1(zu189) double chromosomal mutant showed a phenotype that was indistinguishable from that of the single skn-1(zu67) mutant alone (Lin et al., 1995) , revealing no interaction between the two mutations. This conflicting result might indicate that the double RNAi phenotype does not accurately reflect the simple loss of both gene functions or alternatively that one of the chromosomal mutations insufficiently debilitates the corresponding gene to reveal the synergistic requirement for both SKN-1 and POP-1. To resolve these conflicting observations, we compared chromosomal double mutant embryos with embryos mutant for one of the chromosomal mutations and depleted for the other gene function by RNAi (Table 1) . Consistent with the findings of Lin et al. (1995) , the fraction of embryos lacking gut,¨30%, was similar in skn-1(zu67) and skn-1(zu67); pop-1(zu189) double mutants and was also similar to that in skn-1(RNAi); pop-1(zu189) double mutants. However, only 5% ( P = 0.001) of skn-1(zu67); pop-1(RNAi) embryos produced gut, implying that RNAi targeted to pop-1 is more effective at eliminating pop-1 function than is the zu189 mutation. The zu189 lesion is a transposon insertion in the 3VUTR of the gene, specifically affecting maternal expression of POP-1 (Lin et al., 1995 (Lin et al., , 1998 , suggesting that there may be residual POP-1 activity in zu189 embryos. The difference we observed accounts for why the synergistic requirement for POP-1 and SKN-1 in specification of the endoderm is apparent with pop-1(RNAi), but not pop-1(zu189). We also found that, when skn-1 and pop-1 are inactivated by RNAi simultaneously, 11% (n = 1245) of embryos make endoderm. As the skn-1(zu67) lesion is a nonsense mutation (Bowerman et al., 1993) , the reduced penetrance of skn-1(RNAi); pop-1(RNAi) (11%) over skn-1(zu67); pop-1(RNAi) (5%) may reflect the limited efficacy of targeting two genes by RNAi simultaneously.
Synergy of the endoderm-promoting function of POP-1 with other genes that act in endoderm development
To examine whether the positive requirement for POP-1 in endoderm development is specifically seen only when SKN-1 function is reduced, we tested the ability of pop-1 mutants to synergize with other mutants in which end activity is reduced. The zu247 mutation alters a residue in the zinc finger of END-3, the redundant partner of END-1 , and appears to be hypomorphic (Maduro et al., in press) , while the ok1448 lesion deletes the END-3 DNA-binding domain and is predicted to be a molecular null (our unpublished observations). We found that, while 91% (n = 247) of end-3(zu247) mutants made intestine, only 14% (n = 78) of end-3(zu247); pop-1(zu189) animals and 3% (n = 175) of pop-1(RNAi); end-3(zu247) animals did (Table 1) . Similar results were obtained with the end-3 molecular null (Table 1) : only 1% of pop-1(RNAi); end-3(ok1448) double mutants made endoderm. Thus, elimination of pop-1 function is highly synergistic with reduced end-3 function, which otherwise results in a very mild phenotype.
We also found that loss of pop-1 function strongly synergizes with absence of zygotic MED activity: while 45% (n = 260) of med-1(ok804); sDf127 embryos make endoderm, only 6% (n = 95) of med-1(ok804); sDf127; pop-1(RNAi) embryos do. Together, these results confirm the positive contribution of POP-1 in endoderm specification and show that the activating function of POP-1 is apparent even in the presence of functional SKN-1 (see Discussion).
A Lef-1 site is required for POP-1-dependent end-1 reporter expression Given the requirement for both an Lef-1-like site and an Lef-1-like protein, POP-1, in end-1 activation, it seems likely that Wnt-activated POP-1 may promote end-1 expression by directly interacting with the end-1 promoter. While we have previously shown that GFP-tagged POP-1 can form subnuclear Fspots_ in vivo by binding to extrachromosomal arrays containing the end-1 or end-3 promoters in the MS lineage , we do not know if POP-1 can also act directly on end-1,3 promoters in the E lineage, where it is present at a lower concentration. To assess the requirement for POP-1 and the Lef-1 site in end-1 reporter expression, we attempted to identify the smallest segment of the end-1 promoter that might reveal a requirement for both POP-1 function (in the absence of SKN-1) and the À165 Lef-1 site. A small promoter segment consisting of 310 bp of upstream DNA, either in isolation (E310) or combined with additional upstream sequences (Er880), drives E lineage expression dependent on the SKN-1YMED pathway and the À165 Lef-1 site (Fig. 7) . The most informative construct, E1031, retains sufficient residual expression in skn-1(RNAi) mutants that the positive contribution of POP-1 can be measured: while 18% (n = 201) of skn-1(RNAi) embryos express a reporter derived from E1031, 0% (n = 114) of skn-1(RNAi); pop-1(RNAi) embryos express this construct, demonstrating the POP-1 dependence of transcription from this construct. In contrast, E lineage-specific expression of a reporter carrying a deletion of the À165 Lef-1 site (E1031DLef) depends almost exclusively on SKN-1: only 4% (n = 120; P < 0.0002) of skn-1(RNAi) embryos express this reporter. Hence, the À165 Lef-1 site is important for the positive contribution of POP-1, supporting a direct interaction of Wnt-signaled POP-1 with this site.
Activation of endoderm by the mesectodermal-specifying PAL-1 homeodomain protein
Simultaneous removal of SKN-1 and POP-1 function greatly attenuates but does not abolish, endoderm development, suggesting that at least one additional factor can contribute to endoderm specification. One candidate for such a factor is Caudal/PAL-1, which is present in all descendants of P 1 , including the E cell (Hunter and Kenyon, 1996) . However, PAL-1 is required to specify the fates of C and D, somatic founder cell descendants of P 2 , and pal-1 mutants show no conspicuous defect in endoderm specification (Hunter and Kenyon, 1996) . In embryos that fail to make endoderm as a result of a defect in the SKN-1YMEDYEND pathway, the E cell adopts a C-like fate, producing body wall muscle and hypodermis (Bowerman et al., 1992; Maduro et al., 2001) ; this mesectodermal C-like fate, as with that of the normal C cell, requires PAL-1, demonstrating that PAL-1 is functional in the E cell (Hunter and Kenyon, 1996; Maduro et al., 2001) . To test whether PAL-1 contributes to endoderm specification in the absence of SKN-1 and POP-1, we depleted all three activities by RNAi.
Unexpectedly, we found that endoderm development was completely abrogated in this triple mutant (n = 519; Table 1 ), revealing a positive role for PAL-1 in E specification.
We further tested the effect of depleting pal-1 function in conjunction with skn-1(RNAi) alone, the double mutant strain lacking zygotic med-1 and -2, and the end-3(zu247) mutant. These experiments revealed that PAL-1 function is required for much of the residual endoderm made in each of these mutants (Table 1) . As with POP-1, this requirement for PAL-1 in endoderm specification is normally masked by the SKN-1YMED pathway, and depletion of either pal-1 and pop-1 function alone, or simultaneous removal of both, fails to result in an endoderm specification defect. These results lead to the surprising conclusion that, while PAL-1 is normally required for the development of the mesectodermal progenitor, C, it can also activate endoderm development in the E lineage and that SKN-1, MED-1,2, POP-1, and PAL-1 can all contribute to endoderm specification in C. elegans.
Discussion
We have shown here that the end-1 gene and endoderm specification are regulated by several independent transcriptional inputs, including SKN-1YMED, POP-1, acting both positively (in E) and as a repressor (in MS), and PAL-1, which normally functions to regulate mesectodermal development in the P 2 lineage. Collectively, these findings reveal that a complex transcriptional network is required to establish a relatively simple pattern of expression: activation of end-1 (and, presumably end-3) in a simple clonal lineage descending from the E cell.
Dual action of POP-1 in both negative and positive regulation of endoderm
The terminal Wnt pathway regulator POP-1 establishes transcriptional differences between sister cells throughout C. elegans development (Herman, 2001; Jiang and Sternberg, 1999; Korswagen et al., 2000; Lin et al., 1995 Lin et al., , 1998 . Fig. 7 . Expression of end-1 promoter variants in skn-1 and pop-1 mutants. The À165 Lef-1 site accounts for most of the positive POP-1-dependent input into end-1 expression. Strains bearing different end-1 reporters were tested for E lineage expression dependence on SKN-1 and/or POP-1 activity. Constructs E1720, E1121, and E1031 show a reduction in expression in pop-1(RNAi); skn-1(RNAi) compared to skn-1(RNAi) alone. In construct E1031DLef, in which the À165 Lef-1 site has been deleted, expression is almost completely dependent upon SKN-1 alone, implicating a requirement for the Lef-1 site in activation by POP-1. An asterisk (*) indicates data for an extrachromosomal reporter transgene in which the proportion of untreated embryos that express the reporter was normalized to 100%. The remaining reporters (E1720, Er880, and Er880DLef) were analyzed as integrated arrays.
At the 8-cell embryonic stage, POP-1 is required to make the MS cell different from its sister, E, the endoderm progenitor (Lin et al., 1995) . The role of POP-1 in this asymmetry was thought to be exclusively as a repressor in MS, where non-Wnt-signaled POP-1 blocks activation of the endoderm specification genes end-1 and end-3 by the SKN-1YMED pathway (Calvo et al., 2001; . Although POP-1 is detectable in both the MS and E cells, it does not appear to be required for endoderm specification per se (Calvo et al., 2001; Lin et al., 1995; . However, we now report several lines of evidence for an activating role of POP-1 in endoderm development. First, expression of a minimal end-1 reporter is dependent on POP-1 and a presumptive POP-1 binding site for expression. Second, in mutant backgrounds that reduce expression or activity of the end genes, POP-1 is required for endoderm specification: in skn-1(zu67), skn-1(RNAi), med-1,2(À), end-3(zu247), and end-3(ok1448) mutant backgrounds, depletion of POP-1 activity results in a profound decrease in the levels of end-1 expression and in the proportion of embryos producing endoderm. In the most extreme case, loss of POP-1 leads to the nearly complete (1%) elimination of endoderm in a mutant (end-3(ok1448)) that otherwise makes endoderm in >90% of embryos. This latter finding shows that the positive action of POP-1 in endoderm development is not only required when the SKN-1YMED pathway is inactivated, but also likely functions to elevate end gene expression in the E lineage of normal embryos. We conclude that POP-1 acts dually as a repressor and an activator of end gene expression, likely by directly interacting with end regulatory sequences.
The original analysis of pop-1 (Lin et al., 1998) did not reveal its positive contribution to end gene expression and endoderm development for two reasons. First, the parallel robust contribution of the SKN-1YMED pathway to end-1,3 activation masks the positive input of POP-1 in pop-1 mutants. Second, depletion of pop-1 function by RNAi is more effective at eliminating POP-1 function than is the maternal-specific mutant zu189; hence, the first experiments investigating the phenotype of the pop-1; skn-1 double mutants did not reveal the synergy of the two genes.
Our findings explain the observation that, although skn-1 and med-1,2 mutant embryos invariably fail to produce MS-derived tissues, a substantial fraction still produce endoderm (Bowerman et al., 1992; Maduro et al., 2001 ): Wnt-activated POP-1 stimulates end-1 expression even in the absence of the SKN-1YMED pathway. By genetic criteria, the parallel regulatory inputs of these two pathways are redundant; however, they act by quite distinct mechanisms. Moreover, we have shown that the homeodomain protein PAL-1 can promote endoderm development in parallel with SKN-1YMED and POP-1, accounting for the small fraction of skn-1; pop-1 mutant embryos that still produce endoderm.
Wnt-signaled and Wnt-unsignaled POP-1 may function at distinct regulatory sites While we were able to identify a putative POP-1 site that is required for positive regulation of an end-1 reporter, we have been unable to identify a regulatory element that is required for repression in the MS lineage. Of particular significance, the À165 Lef-1 site is essential for E-specific activation of end-1 but is not required for repression in the MS lineage: construct Er880DLef, in which this site is deleted, gives E lineage-specific expression, albeit at a low frequency. If POP-1 represses end-1 by acting exclusively through this Lef-1 site, then we would expect to observe expression in both the E and MS lineages. Evidence has been obtained for a POP-1 repressive complex that includes the histone deacetylase HDA-1 and the Groucho-like corepressor UNC-37 (Calvo et al., 2001) . Derepression of an end-1 reporter is observed in the MS lineage in embryos depleted for HDA-1; this effect is enhanced when UNC-37 is simultaneously depleted. One possibility, therefore, is that the SKN-1YMED pathway cannot activate end-1 when POP-1 is present in this repressive complex. We have previously shown that GFP-tagged forms of MED-1 and POP-1 localize to the end-1 promoter in the MS cell, suggesting that the repressive function of POP-1 does not preclude simultaneous binding by MED-1 . We postulate that low affinity sites distributed throughout the end-1 promoter might account for localization of the repressive POP-1 complex; such a possibility would explain why end-1 promoter sub-fragments do not show significant derepression.
How does POP-1 function as an activator in the E cell? TCF/LEF transcription factors are known to activate transcription only when bound to a h-catenin-like protein (Cadigan and Nusse, 1997) . The C. elegans genome encodes three recognizable h-catenins, WRM-1, HMP-2, and BAR-1 (Korswagen et al., 2000; Natarajan et al., 2001) , and a fourth protein, SYS-1, that appears to carry out a similar function (Kidd et al., 2005) . HMP-2 appears to function in cell adhesion as it is the only C. elegans hcatenin that interacts with the cadherin HMR-1 (Costa et al., 1998; Korswagen et al., 2000; Natarajan et al., 2001 ). While POP-1 does not activate transcription of a Tcf target reporter gene in tissue culture, co-expression of POP-1 with SYS-1, BAR-1, or Drosophila Armadillo, but not WRM-1 or HMP-2, does result in activation (Kidd et al., 2005; Korswagen et al., 2000) . Of the four h-catenins, BAR-1 and SYS-1 have been shown to interact directly with POP-1 (Kidd et al., 2005; Korswagen et al., 2000; Natarajan et al., 2001 ); indeed, a BAR-1/POP-1 complex activates postembryonic expression of the Wnt target gene mab-5, and a SYS-1/ POP-1 complex is proposed to activate Wnt-dependent genes required for asymmetrical cell divisions in the somatic gonad (Kidd et al., 2005) . Loss of bar-1 function does not cause an endoderm defect, and bar-1(RNAi) does not enhance skn-1(À) gutlessness (data not shown), suggesting that POP-1 associates with another h-catenin or that BAR-1 and another h-catenin function redundantly. One possibility is that WRM-1 is the h-catenin that functions with POP-1. WRM-1 possesses an activation domain and demonstrates a weak but detectable interaction with POP-1 in a yeast twohybrid assay (Natarajan et al., 2001) ; moreover, when expressed under control of the bar-1 promoter, WRM can substitute for BAR-1 in C. elegans (Natarajan et al., 2001) . In gonadogenesis, depletion of WRM-1 and the Nemo-like kinase LIT-1 results in the same lineage defects as zygotic pop-1 mutants, suggesting that WRM-1 and LIT-1 can contribute to a positive function for POP-1 (Siegfried and Kimble, 2002) . In the early embryo, however, WRM-1/LIT-1 activity is required to block the repressive function of POP-1 (Lo et al., 2004; Rocheleau et al., 1999) . It is therefore not possible to detect the positive contribution of WRM-1 to end-1 activation, as depletion of wrm-1 or lit-1 activity results in the complete absence of endoderm (Rocheleau et al., 1997; Thorpe et al., 1997) . It may be possible, therefore, that WRM-1 fulfils the requirement of the h-catenin -TCF interaction involved in transcriptional activation, as seen in other systems.
A better candidate for the POP-1 coactivator in endoderm specification is the novel Wnt coactivator SYS-1 (Kidd et al., 2005) . A predicted null mutant of sys-1, q736, shows an embryonic lethal phenotype, suggesting that SYS-1 does function in the embryo (Kidd et al., 2005) . However, it is not known when putative zygotic sys-1 activity begins nor is it known how sys-1 may function maternally as weaker sys-1 mutants are sterile (Miskowski et al., 2001 ). As we have shown that positive POP-1 activity is detectable only when endoderm specification has been partially compromised, a role for SYS-1 in endoderm specification may yet be revealed. Therefore, while the mechanism remains to be elucidated, our findings nonetheless implicate a previously unrecognized mechanism for embryonic POP-1 activation in the C. elegans embryo.
A mesectodermal regulatory factor can promote endoderm development
Our experiments also establish an unexpected role for the Caudal-like transcription factor PAL-1 in endoderm development. PAL-1 is normally required for specification of mesectoderm in the P 2 lineage, and pal-1 mutants show no discernible endoderm phenotype (Hunter and Kenyon, 1996) . Why, then, is PAL-1 required for the residual endoderm made in skn-1; pop-1 mutants (see Table 1 )? One possible explanation for this finding is that PAL-1 may bind to the end genes as a means of keeping them repressed in the C lineage; in so doing, it would ensure that SKN-1, which is also present in the C lineage, does not activate the end genes inappropriately. Such a mechanism would be part of the system used to ensure exclusivity of cell fate assignments to early blastomeres (e.g., Cowan and McIntosh, 1985) : a cell in which PAL-1 is active and promotes mesectoderm development is strongly repressed for other pathways of differentiation, including endoderm, thereby ensuring adoption of an exclusive cell fate. GSK-3h, which prevents SKN-1 from activating the meds in the C lineage , thus allowing PAL-1-dependent mesectoderm development, may poise this PAL-1/end interaction toward repression. In the E cell, in which GSK-3h is apparently not active in blocking the SKN-1YMED pathway, PAL-1 may lose its end-repressive activity, allowing PAL-1 bound to the end promoters to activate rather than repress endoderm development.
A revised model for C. elegans endoderm specification
Our results suggest a revised view of endoderm specification (Fig. 8) , in which POP-1, in response to Wnt signaling, is converted from a repressor to an activator of the endoderm-promoting end genes. This POP-1-dependent activating function is not essential for endoderm formation since the comparatively stronger contribution by the SKN-1YMED cascade is unaltered by Wnt signaling in the E cell. In parallel with these factors, Caudal/PAL-1 also contributes to endoderm specification. We propose that the use of POP-1 as both an activator and repressor may occur recursively throughout embryonic development to establish differences between daughter cells arising from anteriorposterior asymmetric cell division. Fig. 8 . Revised model for C. elegans endoderm specification. In the absence of a Wnt signal, an EMS daughter will produce an MS like fate since unsignaled POP-1 blocks activation of the endoderm-specifying genes end-1,3 by the SKN-1YMED cascade. The E fate is specified when an overlapping Wnt/MAPK signal modifies POP-1, resulting in its conversion into an activator of endoderm. The combination of SKN-1YMED, PAL-1, and Wnt/MAPK-modified POP-1 results in activation of end-1,3 and specification of an endodermal fate.
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